Medicare Enrolled
Dr. Nailesh Dave, M.D.
Optician · Lillington, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dave from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dave?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dave
Dr. Nailesh Dave is an optician specialist in Lillington, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dave performed 2,280 Medicare services across 967 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dave received a total of $10,224 from 71 pharmaceutical and/or device companies across 691 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dave is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 28% volume in NC
$10,224 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,280
Medicare services
Top 28% in NC for optician
967
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~114 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
851 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
299 | $87 | $211 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
102 | $61 | $200 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
101 | $72 | $183 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
90 | $0 | $25 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
86 | $126 | $283 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
80 | $129 | $378 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
74 | $153 | $420 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
71 | $46 | $118 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
65 | $192 | $630 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
52 | $186 | $483 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
47 | $180 | $330 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
44 | $118 | $319 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
42 | $123 | $335 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
42 | $67 | $171 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
31 | $95 | $288 |
| New patient office visit, complex (60-74 min) | 29 | $139 | $402 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
28 | $38 | $107 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
26 | $60 | $144 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
25 | $10 | $32 |
| Injection, methylprednisolone acetate, 40 mg | 25 | $6 | $24 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
24 | $322 | $803 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
24 | $4 | $12 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
22 | $283 | $693 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,224
Total received (2018-2024)
Avg $1,461/year across 7 years
Top 13% in NC for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
691
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,224 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,440
2023
$834
2022
$956
2021
$875
2020
$1,342
2019
$2,326
2018
$2,451
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$336
Nevro Corp.
$296
Neurocrine Biosciences, Inc.
$161
Novartis Pharmaceuticals Corporation
$105
Axsome Therapeutics, Inc.
$87
JAZZ PHARMACEUTICALS INC.
$79
Forte Bio-Pharma LLC
$64
ABBVIE INC.
$53
Neurelis, Inc.
$41
Eisai Inc.
$38
SCILEX PHARMACEUTICALS INC.
$30
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$25
SI-BONE, INC.
$24
UCB, Inc.
$23
Collegium Pharmaceutical, Inc.
$22
Valinor Pharma, LLC
$22
Lundbeck LLC
$21
PFIZER INC.
$14
Top 3 companies account for 55.1% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$1,405
Amgen Inc.
$1,020
Novartis Pharmaceuticals Corporation
$758
Forte Bio-Pharma LLC
$606
Nevro Corp.
$593
Supernus Pharmaceuticals, Inc.
$543
UCB, Inc.
$370
Daiichi Sankyo Inc.
$326
NOVARTIS PHARMACEUTICALS CORPORATION
$307
Biogen, Inc.
$280
Teva Pharmaceuticals USA, Inc.
$275
Allergan Inc.
$215
EMD Serono, Inc.
$170
PFIZER INC.
$169
Neurocrine Biosciences, Inc.
$161
JAZZ PHARMACEUTICALS INC.
$156
Avanir Pharmaceuticals, Inc.
$154
US WorldMeds, LLC
$140
Axsome Therapeutics, Inc.
$129
SK Life Science, Inc.
$128
Jazz Pharmaceuticals Inc.
$124
LivaNova USA, Inc.
$123
AstraZeneca Pharmaceuticals LP
$123
Allergan, Inc.
$116
Lundbeck LLC
$108
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$96
Assertio Therapeutics, Inc.
$94
Neurelis, Inc.
$94
GENZYME CORPORATION
$88
Takeda Pharmaceuticals U.S.A., Inc.
$80
ABBVIE INC.
$80
Biohaven Pharmaceuticals, Inc.
$73
Indivior Inc.
$62
Collegium Pharmaceutical, Inc.
$60
Lilly USA, LLC
$56
Eisai Inc.
$52
SCILEX PHARMACEUTICALS INC.
$46
Pernix Therapeutics Holdings, Inc.
$42
Mitsubishi Tanabe Pharma America, Inc.
$41
Vertical Pharmaceuticals, LLC
$41
Biohaven Pharmaceutical Holding Company Ltd.
$41
Sentynl Therapeutics, Inc.
$39
Harmony Biosciences LLC
$38
Bayer HealthCare Pharmaceuticals Inc.
$36
Avion Pharmaceuticals
$34
AbbVie Inc.
$33
Mallinckrodt LLC
$31
ASSERTIO THERAPEUTICS, Inc.
$30
Upsher-Smith Laboratories LLC
$30
MDD US Operations, LLC
$26
Scilex Pharmaceuticals Inc.
$24
Janssen Pharmaceuticals, Inc
$24
SI-BONE, INC.
$24
Celgene Corporation
$22
Virtus Pharmaceuticals LLC
$22
Alexion Pharmaceuticals, Inc.
$22
Valinor Pharma, LLC
$22
FIDIA PHARMA USA INC.
$22
EISAI INC.
$21
Medtronic, Inc.
$20
Siemens Medical Solutions USA, Inc.
$18
Hikma Pharmaceuticals USA
$18
GRT US Holding, Inc.
$16
Mallinckrodt Hospital Products Inc.
$15
Radius Health, Inc.
$14
Bausch Health US, LLC
$14
Corium, LLC
$14
Mallinckrodt Enterprises LLC
$13
Egalet US Inc
$13
Kaleo, Inc.
$11
Medtronic USA, Inc.
$11
Top 3 companies account for 31.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADLARITY · AIMOVIG · AJOVY · APOKYN · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Amitiza · Austedo XR · BOTOX · Betaseron · Briviact · Cambia · Cios Select · Dhivy · EMBEDA · EMGALITY · ETERNA · Evzio · Fycompa · GILENYA · Gralise · HYALGAN · INGREZZA · KESIMPTA · Kloxxado · LEMTRADA · LEVORPHANOL TARTRATE · LINZESS · LYRICA · Leqembi · Levorphanol · Levorphanol Tartrate · Lucemyra/Lofexidine · MAYZENT · MIGRANAL · MOVANTIK · MYOBLOC · Mavenclad · Morphabond ER · NALOCET · NUEDEXTA · NURTEC ODT · Nalocet · Neupro · Neuromodulation Dspsbls and Accs · Nucynta · OXTELLAR XR · Octrode SCS Leads · Omnia · PROCLAIM · PressureWire FFR · Proclaim Family of SCS IPGs · QULIPTA · Qutenza · RELEXXII · RELISTOR · RELISTOR ORAL · Radicava · Rebif · SCS leads · SENSIGHT · SOLIRIS · SPRIX · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SUNOSI · Senza · Spinal Cord Stimulation Accessories · Sunosi · TECFIDERA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trintellix · Tymlos · UBRELVY · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · Vimpat · WAKIX · Wakix · XTAMPZA · XYREM · XYWAV · Xyrem · ZEPOSIA · ZOHYDRO ER · ZTLido · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
46
Per 100K population
33.7
County median income
$69,012
Nearest hospital
GOOD HOPE HOSPITAL, INC
8.9 mi
8.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dave is a clinical cardiology specialist, with above-average Medicare volume (top 28% in NC), with low-engagement industry engagement in the top 13% of NC peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dave experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Dave performed 851 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dave receive payments from pharmaceutical companies?
Yes. Dr. Dave received a total of $10,224 from 71 companies across 691 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dave's costs compare to other opticians in Lillington?
Dr. Dave's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dave) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Lillington
Browse opticians in Lillington ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NC
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NC
Which NC opticians receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology